Clinical Trial Detail

NCT ID NCT03970226
Title Tocilizumab in Children With ACP
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Colorado, Denver
Indications

adamantinous craniopharyngioma

Therapies

Tocilizumab

Age Groups: adult child

No variant requirements are available.